David R. McAvoy's Net Worth
$613 Thousand
Who is David R. McAvoy?
David R. McAvoy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Brickell Biotech, Inc., ENDOCYTE INC, and TEVA PHARMACEUTICAL INDUSTRIES LTD.
SEC CIK
David R. McAvoy's CIK is 0001758842
Past Insider Trading and Trends
2020 was David R. McAvoy's most active year for acquiring shares with 5 total transactions. David R. McAvoy's most active month to acquire stocks was the month of February. 2018 was David R. McAvoy's most active year for disposing of shares, totalling 3 transactions. David R. McAvoy's most active month to dispose stocks was the month of November. 2020 saw David R. McAvoy paying a total of $52,213.27 for 452,396 shares, this is the most they've acquired in one year. In 2018 David R. McAvoy cashed out on 63,369 shares for a total of $1,409,856.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Brickell Biotech, Inc. (FRTX) Snapshot price: $0.95
Gen Counsel, CCO, & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +369.76% | 12.64K |
$0.98 | -$7,209.37 | 16.06K |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +16.36% | 18.12K |
$0.67 | $12,137.64 | 128.88K |
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +27.11% | 26.6K |
$0.80 | $21,281.60 | 124.73K |
May 17
| |||
Form 4
| +21.41% | 16.25K |
$1.14 | -$9,975.00 | 92.13K |
Mar 16
| |||
Form 4
| +37.95% | 22.53K |
$0.84 | $18,752.07 | 81.88K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +105.23% | 30.43K |
—
|
—
| 59.36K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOCYTE INC No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.87K |
$24.00 | -$620,856.00 |
0
|
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Snapshot price: $18.06
EVP, Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||